IDH1 and astrocytoma (excluding glioblastoma): As patient age and IDH mutation status are highly correlated (e.g., the median age at diagnosis was reported to be 37 years for IDH-mutant astrocytomas and 65 years for IDH-wildtype astrocytomas1), integration of patient age into multi-modal predictions further improved performance74–76.